COMP <GO>
INVA vs MRK // REVENUE GROWTH (YOY)
Innoviva Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: INVA 5
— MRK 4
▲ REVENUE GROWTH (YOY) LEADER: INVA
LAST: $21.22 (-0.42%) • MKT CAP: $1.54B
revenue-growth
14.70%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
revenue-growth
1.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INVA VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INVA | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.80% | 74.80% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.70% | 20.70% | -6.00 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.6x | 15.3x | -7.70 | INVA | /valuation <GO> |
| Free Cash Flow Yield | 12.72% | 3.42% | +9.30 | INVA | /fcf-yield <GO> |
| Operating Margin | 39.80% | 34.30% | +5.50 | INVA | /operating-margins <GO> |
| Net Profit Margin | — | 28.10% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 14.70% | 1.30% | +13.40 | INVA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.19 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.7 | 51.7 | +3.00 | INVA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.54B | $361.02B | -$359.48B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INVA REV | MRK REV | INVA GROSS % | MRK GROSS % | INVA FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $411.3M | $65.01B | 74.8% | 74.8% | $195.8M | $12.36B |
| FY 2024 | $358.7M | $64.17B | 82.6% | 76.3% | $188.4M | $18.10B |
| FY 2023 | $310.5M | $60.12B | — | — | $141.1M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INVA // BETA —
MRK // BETA 0.92